Cognitive Improvement by Activation of 7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|3|323-343

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.3, 2010-01, pp. : 323-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agonist activation and -bungarotoxin inhibition of wild type and mutant 7 nicotinic acetylcholine receptors

By Kempsill F.E.J.   Covernton P.J.O.   Whiting P.J.   Connolly J.G.  

European Journal of Pharmacology, Vol. 383, Iss. 3, 1999-11 ,pp. : 347-359

Elsevier

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Acetylcholine Receptors and Epilepsy

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 443-448

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Acetylcholine Receptors and Imaging

By  

Current Pharmaceutical Design, Vol. 6, Iss. 11, 2000-07 ,pp. : 1143-1157

Bentham Science Publishers

Access to resources Recommend Favorite

7 Nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus

By Alkondon M.   Braga M.F.M.   Pereira E.F.R.   Maelicke A.   Albuquerque E.X.  

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 59-67

Elsevier

Access to resources Recommend Favorite